2m 2m 2m 2m 2m 2m 2m
SUTRO BIOPHARMA (STRO)
NASDAQ
$27.05+$2.62 (+10.70%)
Price as of Jun 03, 2026 6:41 PM EDT- $484.4MMarket Cap
- 167.49%1-Year Change
- BiotechnologyIndustry
SUTRO BIOPHARMA (STRO)
$27.05+$2.62 (+10.70%)
STRO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $24.43 | ||
Change | -$3.82 (-13.52%) | ||
Open | $27.87 | ||
High | $28.52 | ||
Low | $24.39 | ||
Previous Close | $28.25 | ||
Volume | 332,431 | ||
30-Day Average Volume | 317,722 | ||
1-Week Change | -10.77% | ||
1-Month Change | -31.36% | ||
1-Year Change | 167.49% | ||
3-Year Change | -48.24% | ||
5-Year Change | -86.45% | ||
Fundamentals | |||
Shares Outstanding | 16.6M | ||
Total Assets | $242.0M | ||
Market Cap | $484.4M | ||
Enterprise Value | $410.7M | ||
Period: QTR TTM FY | |||
Revenue | $14.5M | ||
Net Income | -$38.5M | ||
Free Cash Flow | -$42.3M | ||
EBIT | -$38.5M | ||
EBITDA | -$37.2M | ||
Net Working Capital | $150.2M | ||
EPS | -$2.94 | ||
Enterprise Value/EBITDA | -11 | ||
Enterprise Value/Revenue | 28 | ||
P/B | -7 | ||
P/E | -10 | ||
PEG | 0 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 12/03/2025 | ||
Earnings & Revenue